These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 28117910

  • 1. Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation.
    Rajendran R, Giraldo-Velásquez M, Stadelmann C, Berghoff M.
    Brain Pathol; 2018 Mar; 28(2):212-224. PubMed ID: 28117910
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling.
    Kamali S, Rajendran R, Stadelmann C, Karnati S, Rajendran V, Giraldo-Velasquez M, Berghoff M.
    Brain Pathol; 2021 Mar; 31(2):297-311. PubMed ID: 33103299
    [Abstract] [Full Text] [Related]

  • 4. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
    Rajendran R, Böttiger G, Stadelmann C, Karnati S, Berghoff M.
    Cells; 2021 Apr 13; 10(4):. PubMed ID: 33924474
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.
    Bryant MR, Marta CB, Kim FS, Bansal R.
    Glia; 2009 Jul 13; 57(9):935-46. PubMed ID: 19053057
    [Abstract] [Full Text] [Related]

  • 8. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S, Ozturk E, Azari MF, Kenny R, Lee JY, Magee KA, Harvey AR, McDonald C, Taghian K, Moussa L, Mun Aui P, Siatskas C, Litwak S, Fehlings MG, Strittmatter SM, Bernard CC.
    Brain; 2012 Jun 13; 135(Pt 6):1794-818. PubMed ID: 22544872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes.
    Rajendran R, Böttiger G, Dentzien N, Rajendran V, Sharifi B, Ergün S, Stadelmann C, Karnati S, Berghoff M.
    Cells; 2021 May 25; 10(6):. PubMed ID: 34070622
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination.
    Zhou YX, Pannu R, Le TQ, Armstrong RC.
    Neurobiol Dis; 2012 Jan 25; 45(1):196-205. PubMed ID: 21854849
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.
    Furusho M, Roulois AJ, Franklin RJ, Bansal R.
    Glia; 2015 Oct 25; 63(10):1714-28. PubMed ID: 25913734
    [Abstract] [Full Text] [Related]

  • 13. Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation.
    Herrero-Herranz E, Pardo LA, Bunt G, Gold R, Stühmer W, Linker RA.
    Am J Pathol; 2007 Aug 25; 171(2):589-98. PubMed ID: 17600124
    [Abstract] [Full Text] [Related]

  • 14. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
    Fletcher JL, Wood RJ, Nguyen J, Norman EML, Jun CMK, Prawdiuk AR, Biemond M, Nguyen HTH, Northfield SE, Hughes RA, Gonsalvez DG, Xiao J, Murray SS.
    J Neurosci; 2018 Aug 08; 38(32):7088-7099. PubMed ID: 29976621
    [Abstract] [Full Text] [Related]

  • 15. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Lühder F, Gold R.
    Brain; 2010 Aug 08; 133(Pt 8):2248-63. PubMed ID: 20826430
    [Abstract] [Full Text] [Related]

  • 16. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.
    Bannerman P, Hahn A, Soulika A, Gallo V, Pleasure D.
    Glia; 2007 Jan 01; 55(1):57-64. PubMed ID: 17009237
    [Abstract] [Full Text] [Related]

  • 17. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M, Yamasaki R, Li G, Masaki K, Yamaguchi H, Fujita A, Isobe N, Kira JI.
    Front Immunol; 2018 Jan 01; 9():2588. PubMed ID: 30464764
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis.
    Rajendran R, Rajendran V, Böttiger G, Stadelmann C, Shirvanchi K, von Au L, Bhushan S, Wallendszus N, Schunin D, Westbrock V, Liebisch G, Ergün S, Karnati S, Berghoff M.
    Br J Pharmacol; 2023 Dec 01; 180(23):2989-3007. PubMed ID: 37400950
    [Abstract] [Full Text] [Related]

  • 20. FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
    Mierzwa AJ, Zhou YX, Hibbits N, Vana AC, Armstrong RC.
    Neurosci Lett; 2013 Aug 26; 548():280-5. PubMed ID: 23684572
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.